Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Advances in the treatment of coronary artery disease remained steady in 2025, as in recent years, but the past 12 months also ...

The FDA approved the first oral GLP-1 for lowering body weight according to a press release from Novo Nordisk. Oral ...

Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains controversial, with conflicting evidence from landmark trials. We aimed to assess the ...

The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...

95% of STEMI patients achieved FMC-to-device times of 90 minutes or less (up from 50–66.7% in 2024). Median FMC-to-device times also dropped to 60–78 minutes (down from 87–95 minutes in 2024).” Before ...

In this week’s View, Dr. Eagle looks at frailty status and increased risk of mortality in patients who undergo percutaneous coronary intervention (PCI). He then discusses the timely treatment and ...

Every year, thousands of Texans face the terror of a sudden heart attack, and their survival depends on immediate intervention and treatment. For those suffering from ...

Every year, thousands of Texans face the terror of a sudden heart attack, and their survival depends on immediate intervention and treatment. For those suffering from ...

aDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the Netherlands bDepartment of Health Technology and Services Research, Faculty of Behavioural, Management and ...